← Back to Search

Electrical Stimulation for Peripheral Neuropathy (SELECT Trial)

N/A
Recruiting
Research Sponsored by Epineuron Technologies Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1.5 years
Awards & highlights

SELECT Trial Summary

This trial will test an electrical stimulation system to help treat elbow-related nerve problems.

Who is the study for?
This trial is for individuals with ulnar neuropathy at the elbow, which is a condition affecting the nerve on the inner side of the elbow. It's not suitable for people who have an active implanted device or peripheral neuropathy that affects nerves other than the one of interest.Check my eligibility
What is being tested?
The study is testing a new temporary nerve stimulation system designed to be used after surgery for cubital tunnel syndrome. The goal is to see if this electrical stimulation can help improve recovery outcomes.See study design
What are the potential side effects?
Potential side effects may include discomfort at the site of stimulation, skin irritation, and possible muscle twitching during use. Since it's a novel system, part of the study will monitor for any unexpected reactions.

SELECT Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1.5 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1.5 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Eligibility Rate
Recruitment Rate
Retention Rate
Other outcome measures
Electromyography (EMG) Denervation Absence/Presence
Grip strength
Nerve Conduction Study (NCS)
+4 more

SELECT Trial Design

2Treatment groups
Active Control
Group I: ControlActive Control1 Intervention
Standard of care only.
Group II: Experimental InterventionActive Control1 Intervention
Standard of care plus therapy, which consists of a single, 1 hour dose of electrical stimulation.

Find a Location

Who is running the clinical trial?

Federal Economic Development Agency for Southern Ontario (FedDev Ontario)OTHER
3 Previous Clinical Trials
562 Total Patients Enrolled
Epineuron Technologies Inc.Lead Sponsor
2 Previous Clinical Trials
135 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is it feasible to join this research experiment at the present moment?

"Currently, this clinical trial is in the recruitment stage. The study was initially posted on November 1st 2023 and underwent its last update two days later."

Answered by AI

How many participants are eligible for the trial?

"Affirmative. According to clinicaltrials.gov, this trial which was first advertised on November 1st 2023 is currently recruiting patients; a total of 26 need to be enrolled at two different medical centres."

Answered by AI

Are there eligibility criteria for participation in this clinical testing?

"The current medical trial is seeking 26 individuals with peripheral neuropathy and ulnar neuropathy at the elbow, aged between 18-80 years old."

Answered by AI

Does this experiment solicit the involvement of those aged 55 and above?

"The parameters for selection into this experiment necessitate that participants are aged between 18 and 80. Separate trials exist for those younger than 18 and seniors over 65, with 6 study groups and 170 respectively."

Answered by AI
~17 spots leftby Dec 2025